TrialAlzheimer disease and associated disorders

Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.

George T Grossberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.